randomized phase ii studies of cisplatin and a combination of cyclophosphamide-doxorubicin-cisplatin ( cap ) in patients with progestin-refractory advanced endometrial carcinoma .
C0008838
cisplatin
C0280547
cyclophosphamide-doxorubicin-cisplatin